arrow
Y

Yoji Ishizu

Nagoya University Hospital
H指数:26
被引数:1,980

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: A systematic review

肌少症和脆弱性对代偿期肝硬化失代偿的影响:一项系统综述

2025-10-210
OAAI
Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD)

酒精摄入和肌肉质量对代谢功能障碍和酒精相关肝病(MetALD)以及代谢功能障碍相关脂肪性肝病(MASLD)中骨矿物质密度的影响

2025-07-070
OA
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study
2025-02-180
OAAI
Clinical features and pathological findings by liver biopsy in patients with immune-related sclerosing cholangitis induced by immune checkpoint inhibitors

免疫检查点抑制剂诱导的免疫相关硬化性胆管炎患者的临床特征和肝活检病理结果

2025-01-010
PRE
Reply - Letter to the editor
2024-08-010
PRE
A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria
2023-10-252
PRE
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis
2023-05-123
OA